Case Report: Findings Suggestive of Paraclinical Progressive Multifocal Leukoencephalopathy and Lung Cancer-Derived Brain Metastases in an MS Patient Treated With Fingolimod

Case Report: Findings Suggestive of Paraclinical Progressive Multifocal Leukoencephalopathy and Lung Cancer-Derived Brain Metastases in an MS Patient Treated With Fingolimod

Fingolimod represents a highly effective disease-modifying drug in patients with active relapsing-remitting multiple sclerosis (RRMS). Its immunosuppressive effects can mediate adverse events like increased risk of cancer development or appearance of opportunistic infections. Progressive multifocal...

Full description

Bibliographic Details
Main Authors: Fabian Maass, Philipp von Gottberg, Jonas Franz, Christine Stadelmann, Mathias Bähr, Martin S. Weber
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
fingolimod (FTY720)
lung cancer
RRMS (relapsing-Remitting MS)
PML–progressive multifocal leucoencephalopathy
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.561158/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.561158/full

Similar Items